Literature DB >> 25405885

Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.

Nicholas M Chesarino1, Temet M McMichael, Jacob S Yount.   

Abstract

IFITM3 restricts cellular infection by multiple important viral pathogens, and is particularly critical for the innate immune response against influenza virus. Expression of IFITM3 expands acidic endolysosomal compartments and prevents fusion of endocytosed viruses, leading to their degradation. This small, 133 amino acid, antiviral protein is controlled by at least four distinct post-translational modifications. Positive regulation of IFITM3 antiviral activity is provided by S-palmitoylation, while negative regulatory mechanisms include lysine ubiquitination, lysine methylation and tyrosine phosphorylation. Herein, we describe specific insights into IFITM3 trafficking and activity that were provided by studies of IFITM3 post-translational modifications, and discuss evidence suggesting that IFITM3 adopts multiple membrane topologies involving at least one intramembrane domain in its antivirally active conformation.

Entities:  

Keywords:  IFITM3; antiviral; intramembrane domain; methylation; palmitoylation; phosphorylation; post-translational modification; ubiquitination

Mesh:

Substances:

Year:  2014        PMID: 25405885      PMCID: PMC4254935          DOI: 10.2217/fmb.14.65

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  79 in total

1.  Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation.

Authors:  Zhao Shan; Qinglin Han; Jia Nie; Xuezhi Cao; Zuojia Chen; Shuying Yin; Yayi Gao; Fang Lin; Xiaohui Zhou; Ke Xu; Huimin Fan; Zhikang Qian; Bing Sun; Jin Zhong; Bin Li; Andy Tsun
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

2.  Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection.

Authors:  Zhongfang Wang; Anli Zhang; Yanmin Wan; Xinian Liu; Chao Qiu; Xiuhong Xi; Yanqin Ren; Jing Wang; Yuan Dong; Meijuan Bao; Liangzhu Li; Mingzhe Zhou; Songhua Yuan; Jun Sun; Zhaoqin Zhu; Liang Chen; Qingsheng Li; Zhiyong Zhang; Xiaoyan Zhang; Shuihua Lu; Peter C Doherty; Katherine Kedzierska; Jianqing Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

3.  Interferon-induced transmembrane protein 3 is a type II transmembrane protein.

Authors:  Charles C Bailey; Hema R Kondur; I-Chueh Huang; Michael Farzan
Journal:  J Biol Chem       Date:  2013-09-25       Impact factor: 5.157

4.  Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells.

Authors:  Takashi Tsukamoto; Xianglan Li; Hiromi Morita; Takashi Minowa; Tomoyasu Aizawa; Nobutaka Hanagata; Makoto Demura
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 5.  IFITMs restrict the replication of multiple pathogenic viruses.

Authors:  Jill M Perreira; Christopher R Chin; Eric M Feeley; Abraham L Brass
Journal:  J Mol Biol       Date:  2013-09-25       Impact factor: 5.469

6.  Evidence for Paralichthys olivaceus IFITM1 antiviral effect by impeding viral entry into target cells.

Authors:  Rong Zhu; Jun Wang; Xiao-Ying Lei; Jian-Fang Gui; Qi-Ya Zhang
Journal:  Fish Shellfish Immunol       Date:  2013-07-10       Impact factor: 4.581

7.  Chicken interferon-inducible transmembrane protein 3 restricts influenza viruses and lyssaviruses in vitro.

Authors:  S E Smith; M S Gibson; R S Wash; F Ferrara; E Wright; N Temperton; P Kellam; M Fife
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

Review 8.  Lipids in innate antiviral defense.

Authors:  John W Schoggins; Glenn Randall
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

9.  Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model.

Authors:  Aaron R Everitt; Simon Clare; Jacqueline U McDonald; Leanne Kane; Katherine Harcourt; Malika Ahras; Amar Lall; Christine Hale; Angela Rodgers; Douglas B Young; Ashraful Haque; Oliver Billker; John S Tregoning; Gordon Dougan; Paul Kellam
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

10.  Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.

Authors:  Tsai-Yu Lin; Christopher R Chin; Aaron R Everitt; Simon Clare; Jill M Perreira; George Savidis; Aaron M Aker; Sinu P John; David Sarlah; Erick M Carreira; Stephen J Elledge; Paul Kellam; Abraham L Brass
Journal:  Cell Rep       Date:  2013-11-21       Impact factor: 9.423

View more
  36 in total

1.  Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.

Authors:  Graham A D Blyth; Wing Fuk Chan; Robert G Webster; Katharine E Magor
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

2.  IFITM3 requires an amphipathic helix for antiviral activity.

Authors:  Nicholas M Chesarino; Alex A Compton; Temet M McMichael; Adam D Kenney; Lizhi Zhang; Victoria Soewarna; Matthew Davis; Olivier Schwartz; Jacob S Yount
Journal:  EMBO Rep       Date:  2017-08-23       Impact factor: 8.807

3.  Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.

Authors:  Xiangjie Sun; Hui Zeng; Amrita Kumar; Jessica A Belser; Taronna R Maines; Terrence M Tumpey
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

4.  IFITM3 Restricts Human Metapneumovirus Infection.

Authors:  Temet M McMichael; Yu Zhang; Adam D Kenney; Lizhi Zhang; Ashley Zani; Mijia Lu; Mahesh Chemudupati; Jianrong Li; Jacob S Yount
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

5.  Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.

Authors:  Xuesen Zhao; Mohit Sehgal; Zhifei Hou; Junjun Cheng; Sainan Shu; Shuo Wu; Fang Guo; Sylvain J Le Marchand; Hanxin Lin; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses.

Authors:  Subhajit Poddar; Jennifer L Hyde; Matthew J Gorman; Michael Farzan; Michael S Diamond
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 7.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

8.  The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity.

Authors:  Temet M McMichael; Lizhi Zhang; Mahesh Chemudupati; Jocelyn C Hach; Adam D Kenney; Howard C Hang; Jacob S Yount
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

9.  The Indirect Antiviral Potential of Long Noncoding RNAs Encoded by IFITM Pseudogenes.

Authors:  Kazi Rahman; Alex A Compton
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

10.  Site-Specific Lipidation Enhances IFITM3 Membrane Interactions and Antiviral Activity.

Authors:  Emma H Garst; Hwayoung Lee; Tandrila Das; Shibani Bhattacharya; Avital Percher; Rafal Wiewiora; Isaac P Witte; Yumeng Li; Tao Peng; Wonpil Im; Howard C Hang
Journal:  ACS Chem Biol       Date:  2021-04-22       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.